Runny nose

Emoxipin - instructions for use, analogues, reviews and prices. The use of emoxipine for the treatment of ophthalmic diseases

One ampoule contains 1 milliliter of solution, which contains 2-ethyl−6-methyl−3-hydroxypyridine hydrochloride (emoksipina ) 0.01 g. Ampoules are used to administer Emoxipine intramuscularly or intravenously.

Emoxipin 1, which is used in ophthalmology, has similar composition active substance, it just differs in the form of release: the ampoules are replaced by more convenient bottles with dispensers at the end, which allows you to measure exactly one drop of the substance for each eye.

Release form

The drug is released in ampoules with different dosages. Each package of Emoxipin contains five ampoules with the dosage indicated on the package.

Eye drops Available in a 5 ml bottle with a pipette.

Pharmacological action

Emoxipine (INN - Emoxipine) is an angioprotector that reduces the level of permeability vascular walls due to the acceleration of free radical processes, the drug is also antihypoxant . Emoxipine will reduce the level of blood viscosity, the permeability of vascular walls and the tendency to develop hemorrhages. In addition, the active ingredients of the drug will increase the level of cyclic nucleotides in brain tissue and blood platelets.

The fibrinolytic activity of the drug is manifested in the fact that in the case of an acute period, administration can be extended coronary vessels, thereby limiting the developing outbreak. Also, the conduction and contractility of the heart will be improved.

As an ophthalmic substance, Emoxipin has retinoprotective properties; it protects the retina from the action of high-intensity light rays. Emoxipin drops will help to dissolve intraocular hemorrhages and improve the process of microcirculation in the eye.

Pharmacodynamics and pharmacokinetics

Pharmacodynamics

Positive impact on blood clotting : due to reduction general index coagulation and reduction of platelet aggregation, the drug prolongs blood clotting time. Under the influence of the drug, the membranes of cells and blood vessels are stabilized and increase their resistance to potential mechanical injuries.

Effective inhibition of free radical oxidation of lipids contained in biomembranes. Increased activity of enzymes responsible for antioxidant function. Capable of providing hypolipidemic effect by reducing the synthesis of triglycerides.

Taking Emoxipin can reduce symptoms cerebral hemodysfunction . Renders positive influence on the resistance of the cerebral cortex to and. Corrects autonomic dysfunctions in cases of violation cerebral circulation.

Emoxipine has a clear cardioprotective effect. The cardiovascular system will be protected if ischemic myocardial damage : The medicine blocks its spread, also dilating the coronary vessels.

As eye drops Emoxipin protects the retina from potential damage due to exposure to light rays high intensity. In addition, thanks to the drug, it is possible to resolve hemorrhages inside the eye.

Pharmacokinetics

In the case of intravenous administration of a dose of 10 mg per 1 kg of patient weight, very low rate half-elimination of the drug . Elimination constant - 0.041 min; apparent volume of distribution - 5.2 l; the total clearance rate is 214.8 ml per minute.

The drug quickly penetrates organs and tissues human body and that's exactly what happens.

The pharmacokinetics of Emoxipine may vary depending on the patient's condition. For example, in the case pathological condition coronary occlusion , the rate at which the drug is eliminated will be reduced, making it more bioavailable.

In the case of retrobulbar administration of Emoxipine, the active ingredients of the drug appear almost immediately in the blood, stably high level persists for two hours, and 24 hours after administration, the trace of administration is practically completely absent in the blood. A certain concentration of the drug remains in the eye tissues.

Indications for use of Emoxipin

As eye drops indications for use are:

intraocular hemorrhages ;
thrombosis V central vein retina and its branches;
retinal protection after laser coagulation and high intensity light (in the case of sun and laser burns).

Indications for use Emoxipin injections:

complicated myopathy ;
central chorioretinal dystrophies.

Emoxipin injections are also used in cases of chronic and acute cerebral circulatory disorders , if the cause of these disorders is hemorrhagic and ischemic disorders. If necessary, the drug can be administered either as an intramuscular injection or as a intravenous injection in ampoules.

Contraindications

Application this drug Contraindicated during pregnancy and in case of individual hypersensitivity to one of the components.

Side effects

As adverse reactions may appear excitation , which after a short time interval will change drowsiness . Maybe increased blood pressure and appearance . Local reactions may manifest as pain, itching, burning sensation, redness and thickening of the paraorbital tissues.

Instructions for use of Emoxipin (Method and dosage)

Instructions for Emoxipin - eye drops

In the case of retrobulbar administration of the drug, a one percent solution in a dosage of 0.5 ml is administered once a day for 10–15 days. If the medicine is administered subconjunctivally and parabulbarly, then 0.2 to 0.5 ml of the drug is administered once a day for 10–30 days.

If it is necessary to protect the retina, the drug is administered retrobulbarly in a dosage of 0.5 ml per day and one hour before laser coagulation. The course depends on the degree of burns received during laser coagulation; in most cases, retrobulbar drops are used once a day for two to ten days.

Instructions for Emoxipin - solution for injection

In cardiology and neurology, the drug is mainly used intravenously using a dropper, at a rate of 20–40 drops per minute. The dose of the drug is 20-30 ml of a three percent solution. Droppers can be placed one to three times a day for 5–15 days. The duration of treatment directly depends on the type of patient’s disease. At the end of the drips they switch to intramuscular injections drug: administer 3-5 ml of 3% solution 2-3 times a day. Well intramuscular injection ranges from 10 to 30 days.

Emoxipine is not released into tablet form, therefore you will not be able to take Emoxipin tablets, because they simply do not exist.

Overdose

In case of overdose of the drug, the appearance or intensification of side effects. In case of an overdose of the drug or its analogues, it may increase, excessive agitation or pain in the cardiac region may appear, headache, nausea , abdominal discomfort. Blood clotting may be impaired.

Treatment of an overdose of Emoxipine and Emoxipine analogues consists of discontinuing the drug and carrying out procedures symptomatic therapy if necessary.

Interaction

When used together with α-tocopherol acetate , perhaps a more active manifestation of the antioxidant properties of Emoxipin. In general, it is not recommended to combine the drug with the use of any other medications without permission from the attending physician.

Terms of sale

The terms of sale of the drug are not limited.

Storage conditions

The drug must be stored in a place protected from light at a temperature not exceeding 25 degrees Celsius.

Composition and release form of the drug

5 ml - ampoules (5) - cardboard packs.
5 ml - ampoules (5) - contour cell packaging (1) - cardboard packs.
5 ml - ampoules (5) - contour cell packaging (2) - cardboard packs.
5 ml - ampoules (5) - contour cell packaging (20) - cardboard packs.
5 ml - ampoules (5) - contour cell packaging (50) - cardboard packs.
5 ml - ampoules (5) - contour cell packaging (100) - cardboard packs.

Pharmacological action

Reduces the permeability of the vascular wall, is an inhibitor of free radical processes, an antihypoxant and an antioxidant.

Reduces blood viscosity and platelet aggregation, increases the content of cyclic nucleotides (cAMP and cGMP) in platelets and brain tissue, has fibrinolytic activity, reduces the permeability of the vascular wall and the risk of hemorrhage, promotes their resorption. Dilates the coronary vessels, in acute period limits the size of the necrosis focus, improves contractility the heart and the function of its conduction system. At elevated blood pressure it has a hypotensive effect. In acute ischemic disorders of cerebral circulation, it reduces the severity of neurological symptoms and increases tissue resistance to hypoxia and ischemia.

It has retinoprotective properties, protects the retina from the damaging effects of high-intensity light, promotes the resorption of intraocular hemorrhages, and improves microcirculation of the eye.

Indications

Included complex therapy: consequences of cerebrovascular accident of ischemic and hemorrhagic nature, head injury, postoperative period epi- and subdural; acute myocardial infarction, prevention of reperfusion syndrome, unstable angina.

Subconjunctival and intraocular hemorrhage, angioretinopathy (including diabetic), chorioretinal dystrophy (including atherosclerotic origin), dystrophic keratitis, retinal vascular thrombosis, complications of myopia, protection of the cornea (when wearing contact lenses) and the retina from exposure high-intensity light (laser and solar, with laser coagulation), trauma, inflammation and burns of the cornea, cataracts (including prevention in persons over 40 years of age), surgical interventions in front of the eyes, condition after surgery for detachment choroid.

Contraindications

Hypersensitivity, pregnancy.

Dosage

In neurology and cardiology - intravenous drip (20-40 drops/min), 20-30 ml of 3% solution (600-900 mg) 1-3 times a day for 5-15 days (the drug is first diluted in 200 ml of 0.9% NaCl solution or 5% dextrose solution). The duration of treatment depends on the course of the disease. Subsequently, they switch to intramuscular administration - 3-5 ml of a 3% solution 2-3 times a day for 10-30 days.

In ophthalmology - subconjunctival or parabulbar, 1 time per day or every other day. Subconjunctivally - 0.2-0.5 ml of 1% solution (2-5 mg), parabulbar - 0.5-1 ml of 1% solution (5-1 mg). Duration of treatment - 10-30 days; It is possible to repeat the course 2-3 times a year.

If necessary, retrobulbar 0.5-1 ml of 1% solution once a day for 10-15 days.

To protect the retina during laser coagulation (including limiting and destructive coagulation of tumors) - parabulbar or retrobulbar 0.5-1 ml of 1% solution 24 hours and 1 hour before coagulation; then - in the same doses (0.5 ml of 1% solution) 1 time per day for 2-10 days.

The active component of the drug "Emoxipin" is a powdery compound with a crystalline structure and high degree solubility in water. The active substance has international name- methylethylpyridinol. The drug "Emoxipin" has antioxidant, antiplatelet, and vasoprotective properties. The product can also be used as an antihypoxant.

Antioxidant properties

The drug "Emoxipin" neutralizes the activity of free radicals and ensures the cessation of oxidative chain reactions. This, in turn, helps maintain the integrity of vital DNA biomolecules, membrane cellular structures, enzymes, proteins, etc.

Properties of antihypoxant

This quality allows the medication to prevent oxygen starvation during internal organs. This effect is ensured by transporting a large volume of gas. At the same time, its increased penetration through the vascular wall and cell membrane is noted.

Vasoprotective effect

This property of the drug "Emoxipin" is expressed in the ability to increase the strength, elasticity and smoothness of vascular walls. At the same time, their permeability decreases. Due to the smoothness of the surface of the vessels, the “gluing” of blood elements is reduced, their attachment to the venous and arterial walls. This, in turn, provides the antiplatelet property of the drug. Thanks to the described effect, there is an improvement in blood fluidity - its viscosity decreases. In addition to reducing “sticking,” Emoxipin helps accelerate the resorption of blood clots. By reducing permeability, hemorrhages are prevented. Against the background of cardiac pathologies, the drug "Emoxipin" has a vasodilating effect, localizing and limiting the focus of a heart attack. The medicine helps to strengthen contractions and normalize impulse transmission, preventing disturbances in heart rate. In general, the drug increases the resistance of body tissues to oxygen deficiency and circulatory failure.

Release form

The drug "Emoxipin" is produced in the form of eye drops and solution for injection. The latter is available in two concentrations - three and one percent. The 1% solution is packaged in 1 ml ampoules, and the 3% solution in 5 ml ampoules. Eye drops are a liquid mixture of one percent concentration. The solution is packaged in ampoules of 5 ml. Next, we will consider for what pathologies and conditions the drug “Emoxipin” (eye drops) is prescribed. Information about the dosage and side effects of the medication will also be provided.

Medicine "Emoxipin": indications

The medicine has the ability to improve metabolic processes and blood circulation. The drug allows you to accelerate the resorption of hemorrhages and the movement of small-caliber vessels in the network. In this regard, the drug "Emoxipin" (eye drops) is recommended for:

complicated myopia;
glaucoma;
retinal hemorrhages in elderly patients;
defeats ocular vessels against the background of diabetes mellitus;
dystrophic ophthalmological pathologies;
cataracts;
thrombosis of the central retinal vein or its branches;
use of contact lenses;
burn or inflammation of the cornea;
pathologies associated with oxidative (active) destruction (for example, with a heart attack, skin diseases, stroke);
angina pectoris.

This is a list of main indications. Eye drops are also recommended during the postoperative period. And also to protect vision from exposure to a high-intensity or high-frequency light source (for example, a laser or the sun).

Features of therapy

Under the influence of a drug such as "Emoxipin" (eye drops), hemorrhages of a very different nature, including those provoked by injuries, resolve. Various pathologies dystrophic nature, for example, retinal dystrophy, diabetic retinopathy stop their progression. During therapy, there is a gradual improvement in vision and normalization of eye condition. Thanks to the antiplatelet effect of a drug such as Emoxipin (eye drops), blood clots quickly dissolve and impaired blood circulation is restored. The medication helps reduce the intensity of complications of myopia. When conducting medical manipulations, during which they involved various kinds Light sources, including high-frequency ones, require eye protection. In such cases, eye drops are used. They provide necessary protection from laser and ultraviolet radiation, as well as from burns. During choroidal detachment and in the postoperative period (after surgery for glaucoma), prevention of damage to arteries and veins is necessary. In this regard, the instructions recommend using Emoxipin drops to maintain visual functions.

In addition to ophthalmological pathologies, the medication is prescribed for cardiovascular diseases. This is due to its vasoprotective properties. It is used in the treatment of heart attacks in acute stage, to prevent “reperfusion syndrome”. The use of the drug significantly improves metabolic processes and nutrition of the heart muscle after a heart attack. Unstable angina can be better controlled when using the drug. At the same time, attacks of pain and painful symptoms become more rare and less pronounced. The drug "Emoxipin" is used and in neurological practice. In particular, the drug is prescribed for circulatory disorders in the brain of different origins. Moreover, the medicine is equally effective with a sharply reduced supply and against the background extensive hemorrhages. A remedy is recommended after removal of hematomas located in the epidural and subdural spaces. In such cases, the medication helps normalize blood supply and prevent repeated effusions. Today, the medication is used in the treatment of any conditions that are accompanied by processes of active oxidation - oxidative stress. This phenomenon is observed when there is sufficient wide range pathologies. This is a heart attack, glaucoma, stroke, viral infection and so on.

"Emoxipin" product: instructions for use

Drops are used 2-3 times a day. Therapy is carried out in courses. 1-2 drops of solution are injected into the conjunctival cavity. Course duration is 3-30 days. With normal tolerability and indications, the therapeutic period can be extended to six months. There are no breaks during this. Short courses (up to a month) are held 2-3 times a year.

Special Information

There are cases when several drugs are prescribed. In such situations, the last drug used is Emoxipin. The instructions for using the drops recommend administering them 10-15 minutes after infusion of the previous drug. Subject to availability hypertension therapy is carried out under regular monitoring of blood pressure levels. In addition, it is necessary to monitor blood clotting indicators. It is not allowed to mix the drug "Emoxipin" with other medications. It is not allowed to be administered together with other drugs in the same syringe.

Side effect

Emoxipin drops can cause pain, tingling, and burning in the eyes. As practice shows, these consequences are eliminated on their own after certain time. In some cases, there may be redness or hardening of the tissue around the orbit. In general, the drug is well tolerated.

Who is not prescribed the medication?

According to many experts, the drug "Emoxipin" is enough safe remedy, which has virtually no contraindications. However, medication is not always prescribed. In particular, the drug is contraindicated for pregnant and lactating women, as well as for persons with hypersensitivity to the components of the drug.

Additional information

The drug "Emoxipin", the price of which is from 95 rubles, is a remedy Russian production. This determines its relatively low cost. According to patient reviews, the medication is very effective, but has a significant local irritant effect. This, in turn, creates some inconvenience when using a product such as Emoxipin (eye drops). Analogs of the drug: "Emoxy-Optic", "Emoxibel" and others. If any information not specified in the annotation appears negative consequences or if your condition worsens, you should visit your doctor immediately. Before using the medication, you must read the instructions carefully.

Emoxipin – synthetic antioxidant used in ophthalmic practice – reduces blood viscosity, reduces the permeability of vascular walls, improves microcirculation, and has an antioxidant effect.

In therapeutic practice, Emoxipin is most often used in the treatment of intraocular hemorrhages and degenerative changes.

The drug increases tissue resistance to lack of blood circulation and oxygen, protects retina from harmful high-intensity light exposure, increases the microcirculatory function of the eyes, and has a resolving effect on intraocular hemorrhages.

The active ingredient Emoxipine increases the content of cyclic nucleotides in brain tissue and blood platelets. Taking the drug can reduce the manifestations of cerebral hemodysfunction.

It has a positive effect on the resistance of the cerebral cortex to ischemia and hypoxia. Corrects autonomic dysfunctions in cases of cerebrovascular accident.

The active ingredient of the drug “Emoxipin” is a powdery compound with a crystalline structure and a high degree of solubility in water; it has the international name - methylethylpyridinol. After entering the bloodstream active ingredient strengthens blood vessels, prevents their fragility, thins the blood, thereby preventing the development destructive processes in the lumen of blood vessels.

Emoxipine improves metabolism cellular level, normalizes local and systemic blood circulation.

Release form:

– Emoxipin eye drops. This is a 1% solution of the drug. 1 ml contains emoxypine (methylethylpyridinol hydrochloride) 0.01 g.

– Solutions for injections. They come in different concentrations: 1 and 3 percent. One ampoule contains 1 milliliter of solution, which contains 0.01 g or 0.03 g of 2-ethyl-6-methyl-3-hydroxypyridine hydrochloride (emoxypine).

Indications for use Emoxipin

Treatment and prevention of inflammation and burns of the cornea.
Treatment of hemorrhage in the anterior chamber of the eye.
Myopathy is complicated.
Diabetic retinopathy.
Thrombosis of the central retinal vein and its branches.
Use of contact lenses.
Cataract.
Glaucoma.

Emoxipine is ineffective against diseases and pathologies of the blood vessels of the eye caused by reasons other than mechanical and chemical.

Emoxipine in the form of an injection solution is indicated for the treatment of a number of ophthalmological, neurological and cardiac diseases. It is prescribed by specialists as part of complex therapy for the treatment of:

Cardiac diseases (heart attack, unstable angina, etc.);
Neurological diseases (stroke, condition after TBI (traumatic brain injury), postoperative period of epi- and subdural hematomas);
Oxidative stress.

In this case, both intravenous and intramuscular routes of administration can be prescribed. However, more effective technique is considered to be primary intravenous administration(injection) of Emoxipine, which is then replaced by intramuscular injection.

Instructions for use Emoxipin, dosage

The dosage is prescribed only by the attending physician - an ophthalmologist, and depends on the age and characteristics of the course of the disease.

Drops

Emoxipin eye drops are instilled 1-2 drops into the conjunctival sac 2-3 times a day. The duration of treatment is from 3 to 30 days, depending on the severity of the disease.

The minimum dose is 0.2 ml. Maximum dose– 0.5 ml (which is 5 mg active substance) every day or every other day, depending on the degree of damage or pathology.

Solution for injection

To treat eye diseases, ophthalmologists use a 1% solution, with injections made next to eyeball:

– retrobulbar – a method of delivering the drug directly to the affected areas;
– parabulbar – injection of emoxipine solution using a syringe subcutaneously (lower edge of the eye) in the direction of the equator of the eye;
– subconjunctival – under the conjunctiva (injection of a 1% solution is performed by inserting a needle under the conjunctiva, into the area transitional folds mucous membranes, 0.2-0.5 ml).

Retrobulbar and parabulbar injections are widely used during laser coagulation procedures.

IN in rare cases Emoxipin injections are prescribed in the eyes and temple at the same time.

In ophthalmology - subconjunctival or parabulbar, 1 time per day or every other day. Subconjunctivally - 0.2-0.5 ml of 1% solution (2-5 mg), parabulbar - 0.5-1 ml of 1% solution (5-1 mg).

Features of application

Treatment should be carried out under the control of blood pressure and blood clotting.

Mixing Emoxipin injection solution with other drugs is strictly not recommended.

It is possible to use the drug during lactation ( breastfeeding) strictly according to indications.

The drug does not affect the ability to drive vehicles, precision mechanisms and machinery.

There are cases when several drugs are prescribed. In such situations, Emoxipin is the last drug used. The instructions for use recommend administering the medication 10-15 minutes after the infusion of the previous drug.

Side effects and contraindications Emoxipin

May manifest as symptoms of eye irritation (burning, itching, swelling and redness of the conjunctiva).

Very rarely, blood pressure may increase. Therefore, it is important for hypertensive patients to first consult with a cardiologist.

Sometimes short-term agitation and drowsiness are observed when taking the medication. If a strong burning sensation is observed, rinse the eye and replace the drug with an analogue.

It is also possible that it may appear on the skin allergic reactions accompanied by itching and swelling. To eliminate skin manifestations The use of corticosteroids is recommended.

Overdose

Official data on the appearance of undesirable symptoms when exceeding therapeutic doses There is no drug Emoxipin in the form of eye drops.

In case of an overdose of Emoxipine in the form of a solution, increased side effects and blood clotting disorders may be observed. You should stop using the drug and carry out symptomatic treatment.

Contraindications

Hypersensitivity, pregnancy.

Emoxipine has very few contraindications and is a relatively safe drug.

Analogues of Emoxipine, list of drugs

Analogues of Emoxipine are the following drugs (list):

Quinax;
Methylethylpyridonol-Eskom;
Katachrom;
Taufon;
Emoxy-Optic;
Emoxybel;
Khrustalin.

It is important to understand that analogues are not a complete copy of the drug - instructions for use of Emoxipine, price and reviews do not apply to analogues and cannot be used as a guide in prescribing treatment or dosages. When replacing Emoxipin with an analogue, it is important to consult a specialist.

If any information not specified in the official instructions or a simplified description of the remedy, negative consequences or worsening of the condition, you should visit a doctor immediately. Before using Emoxipin, you must read the attached instructions carefully.

Vitamin eye drops or 1% solution for injection low price category, which affect the oxidative processes in the cell membrane, help tissues tolerate a lack of oxygen, increase the resistance of blood vessels and prevent the formation of blood clots.

Emoxipin ointment and tablets are non-existent forms of this medicine.

On pharmaceutical market presented in two forms:

1% eye drops in 5 ml bottles for retrobulbar use;
1% solution in ampoules for intravenous or intramuscular administration.

Both ampoules and vials are additionally packaged in cardboard box 10 pieces each.

The solution is transparent, almost colorless with a slight yellowish tint.

1 ml of both drops and solution contains 30 mg of the active substance methylethylpyridinol hydrochloride, as well as additional components.

International nonproprietary name

The INN of this drug is methylethylpyridinol. This is also his group name.

ATX

[С05СХ].

Pharmacological action

The action is based on the following properties:

antioxidant;
antihypoxic;
retinoprotective;
inhibition free radicals;
thinning the blood and preventing the formation of blood clots;
fibrinolytic activity;
expansion of coronary vessels;
limiting the focus of necrosis with acute heart attack myocardium;
hypotensive effect;
resorption of hemorrhages;
decreased permeability of blood vessel walls.

Pharmacokinetics

It is quickly distributed in tissues, accumulates there and is metabolized. Excreted from the body through the kidneys.

Why is Emoxipin prescribed?

Indicated for use when:

burns and inflammation of the eyes (if affected by fungi and viruses);
hemorrhages in the anterior chamber of the eye or sclera;
formation of blood clots in the central retinal vein and its branches;
complicated myopia;
eye protection when using contact lenses and for protection from light exposure;
Non-inflammatory retinal vascular pathologies in diabetes or diseases of brain tissue;
glaucoma with retinal detachment in postoperative care;
acute myocardial infarction;
uterine fibroids complicated by bleeding (in a combination of drugs);
disorders of microcirculation of the eye;
cataracts;
cerebral ischemia (to limit hemorrhages);
skin diseases (eczema, etc.);
retinopathy of newborns and rickets;
diseases of the genital organs (uterine fibroids, complicated by bleeding) in complex treatment;
treatment of infections (in complex therapy of influenza);
cerebrovascular accidents;
acute blood loss;
high blood pressure.

The medicine is used in the practice of ophthalmologists, cardiologists, gynecologists, neurologists, and neurosurgeons.

Contraindications

Do not use eye drops or solution for injection if hypersensitivity To active substance, children over 18 years old, during pregnancy and breastfeeding, bleeding disorders.

How to take Emoxipin

Retrobulbar administration is indicated with a solution for instillation into the eyes. Apply for 10 days to 1 month. Dosage: 2-3 times a day, 1-2 drops into the conjunctival cavity. If the course is insufficiently effective, it should be continued for up to six months. The course of treatment can be repeated 2-3 times a year. When a fungal infection occurs (fungal uveitis), it is combined with Clotrimazole ointment.

In neurological, neurosurgical, dermatological and cardiological practice, emoxypine solution for injection is used after preliminary dilution with isotonic sodium chloride solution. It is administered in neurosurgery and neurology in the first 12 days intravenously, 20-30 drops per minute at the rate of 5-10 mg per 1 kg of patient weight. In the next 20 days, switch to 2-3-fold intramuscular injections from 60 to 300 mg per 1 administration.

In cardiology and gynecology, in the first 5-15 days, 600-900 mg is administered intravenously 2-3 times a day at a rate of 20-40 drops per minute. Over the next 10-30 days, the drug is used in the form intramuscular injections 60-300 mg 2-3 times a day.

Also, a 1% solution is applied subconjunctivally and parabulbarly every other day or daily for 10-30 days. Dosage - 0.2 ml, 0.5 ml, 1 ml. The course can be repeated 2-3 times a year.

For diabetes

Diabetes causes non-inflammatory retinal vascular pathologies (retinopathy). In this case, methylethylperidinol is used by instilling 1-2 drops into each eye 2-3 times a day. At diabetes mellitus not compatible with other similar products. The bottle is stored in the refrigerator. The dosage is always prescribed by the doctor depending on the severity of the disease.

Side effects of Emoxipine

Side effects of Emoxipine can manifest themselves as:

reaction disorders nervous system(excessive agitation or drowsiness, headache);
reactions at the injection site (itching, burning, pain, inflammation);
reactions from cardiovascular system(increases blood pressure, pain in the heart);
visual disturbances (swelling and redness, blurred vision);
dyspepsia from the gastrointestinal tract.

Sometimes a bleeding disorder occurs.

Allergies

Allergic reactions are quite common side effects action of the drug. Manifested by urticaria, bronchial asthma and anaphylactic shock.

Impact on the ability to operate machinery

Special instructions

Before using eye drops, it is necessary to remove contact lenses and put them in place 10-15 minutes after the procedure.

Use during pregnancy and lactation

During pregnancy and breastfeeding breast milk not used.

Alcohol compatibility

Not compatible.

Overdose

When using a dosage in excess of the recommended one, the severity of side effects may increase. In this case, treatment should be symptomatic. In case of severe allergic reactions, it is recommended to discontinue the drug and replace it with another.